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Summary
Interleukin 10 (IL-10) and viral IL-10 (v-IL-10) strongly reduced antigen-specific proliferation of 
human T cells and CD 4+ T  cell clones when monocytes were used as antigen-presenting cells. 
In contrast, IL-10 and v-IL-10 did not affect the proliferative responses to antigens presented by 
autologous Epstein-Barr virus-lymphoblastoid cell line (EBV-LCL). Inhibition of antigen-specific 
T cell responses was associated with downregulation of constitutive, as well as interferon 7 -  
or IL-4-induced, class II M HC expression on monocytes by IL-10 and v-IL-10, resulting in the 
reduction in antigen-presenting capacity of these cells. In contrast, IL-10 and v-IL-10 had no effect 
on class II major histocompatibility complex (MHC) expression on EBV-LCL. The reduced antigen- 
presenting capacity of monocytes correlated with a decreased capacity to mobilize intracellular 
Ca2+ in the responder T cell clones. The diminished antigen-presenting capacities of monocytes 
were not due to inhibitory effects of IL-10 and v-IL-10 on antigen processing, since the proliferative 
T cell responses to antigenic peptides, which did not require processing, were equally well inhibited. 
Furthermore, the inhibitory effects of IL-10 and v-IL-10 on antigen-specific proliferative T cell 
responses could not be neutralized by exogenous IL-2 or IL-4. Although IL-10 and v-IL-10 suppressed 
IL-la, IL-ljS, tumor necrosis factor a  (TNF-ai), and IL-6 production by monocytes, it was excluded 
that these cytokines played a role in antigen-specific T cell proliferation, since normal antigen- 
specific responses were observed in the presence of neutralizing anti-ILl, -IL-6 , and -TNF-Oi mAbs. 
Furthermore, addition of saturating concentrations of IL-la, IL-1/3, IL-6 , and TNF-ce to the cultures 
had no effect on the reduced proliferative T cell responses in the presence of IL-10, or v-IL-10. 
Collectively, our data indicate that IL-10 and v-IL-10 can completely prevent antigen-specific T 
cell proliferation by inhibition of the antigen-presenting capacity of monocytes through 
downregulation of class II MHC antigens on monocytes.
B cells, were used as APC (2). It was shown that m-IL-10 
has multiple biological activities. IL-10 has mast cell growth 
factor activity in combination with IL-3 and/or IL-4 (3), and 
T cell growth factor activity on mature and immature mouse 
thymocytes in the presence of IL-2 and IL-4 (4). In addition, 
m-IL-10 increased the expression of class II M HC antigens 
on small murine splenic B cells and enhanced the viability 
of these cells (5). Furthermore, m-IL-10 was shown to be pro­
duced by murine Ly-1+ B cells and B cell lymphomas and 
may act as an autocrine growth factor for these cells (6 ).
Recently, the cDNA encoding for human IL-10 was cloned 
from a cDNA library made from a tetanus toxin (TT)-specific
Murine IL-10 (m-IL-10)1 cytokine synthesis inhibitory factor (CSIF) is produced by T h2 cells and inhibits 
the synthesis of cytokines, particularly of IFN-7 , by Thl, 
but not Th2 cells (1). This inhibitory activity on cytokine 
production by IL-10 was found to be indirect and required 
the presence of APC (1, 2). In addition, it was demonstrated 
that cytokine production by T h l clones was affected only 
when macrophages, but not purified conventional or Lyl +
1 Abbreviations used in this paper: CSIF» cytokine synthesis inhibitory factor; 
FMF, flow microfluorimetry; hsp, heat shock protein; m, murine; TT, 
tetanus toxoid; v, viral.
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CD4+ T cell clone that produced multiple cytokines after 
activation, including IL-2, IFN-7 , IL-4, and IL-5, indicating 
that this clone does not fit the Thl or Th2 subsets (7). Human 
IL10 and m-IL-10 exhibit extensive sequence homology to 
a previously uncharacterized open reading frame in the EBV 
genome, BCRF-1 (7, 8). It was shown that both IL-10 and 
the protein product of BCRF-1, designated viral-IL-10 (v-IL- 
10), exhibited cytokine synthesis inhibitory activity on antigen- 
specific mouse T cell clones and human PBMC activated by 
antigen and macrophages or PH A and anti-CD 3 mAbs, respec­
tively (7, 9), However, v-IL-10 had little murine mast cell 
stimulatory activity or thymocyte growth factor activity, and 
it did not affect class II MHC expression on mouse splenic
B cells (3, 5).
IL-10 affected cytokine synthesis of murine T h l clones, but 
not that of Th2 clones, and the effects of IL-10 on murine 
ThO clones, which are able to produce IL-2, IL-4, IL-5, and 
IFN-7  (10), have not yet been evaluated. Human CD4+ T 
cell clones generally do not display the strict T h l and Th2 
lymphokine production profiles observed for murine CD4+ 
T cell clones (11, 12), and are, in this aspect, more comparable 
to murine ThO cell clones. However, recently we have shown 
that CD4 + T cell clones specific for the house dust mite-de­
rived allergen Der p I isolated from atopic patients produce 
very high quantities of IL-4 and IL-5, whereas the levels of 
IFN- 7  and IL-2  production varied from low to normal (Yssel 
et al., manuscript submitted for publication). On the other 
hand, CD4+ T cell clones specific for the 65-kD heat shock 
protein (hsp) of Mycobacterium leprae (M, leprae) had a “Thl- 
like9’ lymphokine profile, since these clones produced high 
levels of IFN- 7  and very low, or sometimes even undetect­
able, levels of IL-4 and IL-5 (13).
In the present study, the effects of IL-10 and v-IL-10 on 
antigen-specific human T cell responses were investigated. 
It was shown that IL-10 and v-IL-10 strongly blocked the 
antigen-specific proliferative responses of both T cells and 
CD4+ Thl- or Th2-like T cell clones. The inhibitory effects 
on antigen-specific T cell proliferation were only observed 
when monocytes, but not when EBV-LCL* were used as APC. 
In addition, it is shown that IL-10 and v-IL-10 have strong 
downregulatory effects on both constitutive and IL4- or IFN- 
7 -induced class II MHC expression on monocytes, indicating 
that the strongly reduced proliferative T cell responses to­
wards antigens are due to inhibition of antigen-presenting 
capacity of monocytes through downregulation of class II 
MHC antigens on these cells.
Materials and Methods
Cells and Reagents. The TT-specific T cell clone 827 (14), the 
T cell clones NP12, NP14, and NP44, which are specific for the 
major allergen in house dust, D erp  I (Yssel et al., manuscript sub­
mitted for publication), and the 65-kD M. leprae hsp-specific T cell 
clones HY06, RplSll, R2F10, and CAApl515 (13, 15) have all
been described previously. T cell clones (2 x 105/ml) were stimu­
lated at 2-wk intervals by a feeder cell mixture consisting of 
106/ml irradiated (4,000 rad) allogeneic PBL, 105/ml irradiated 
(5,0Q0 rad) cells of the EBV-transformed B cell line (EBV-LCL) JY,
and 0.1 (Jig/m 1 purified PHA (Wellcome Diagnostics, Beckenham, 
Kent, UK) as described (14) and expanded by addition of rIL2, 
The EBV-LCL HSY, which was established from the same donor 
as T cell clones 827 and HY06 (14), NPR, which was derived from 
the same donor as T cell clones NP12, NP14, and NP44 (Yssel et 
al., manuscript submitted for publication), and PZB (15), which 
was HLA-DR identical to the tuberculoid leprosy patient from 
whom the T cell clones Rpl511 and R2F10 were derived, have 
been described. T cell clones and EBV-LCL were cultured in YssePs 
medium (14) supplemented with 1% human AB+ serum. TT was 
generously provided by Dr. Bizzini (Institute Pasteur, Paris, France). 
The D e rp  I cDNA clone was kindly provided by Dr. W. Thomas 
(Princess Margaret Hospital, Perth, Australia), Recombinant Der 
p  I antigen was expressed in Escherichia coli and purified (16). 
M. leprae antigen (CD 104) was a kind gift of Dr. R. J. W. Rees 
(London, UK). The D erp  I-specific peptide (amino acids 89-117) 
and M . leprae 65-kD hsp peptides (amino acids 3-13 and 418-427) 
were made by solid phase peptide synthesis and checked by analyt­
ical reverse phase HPLC and amino acid analysis (17). M leprae- 
specific peptides were kindly provided by Dr. D. C. Anderson 
(University of Washington, Seattle, WA).
Recombinant IL-10 and v-IL-10 were expressed in E. coli and 
purified (16). Purified human r-IL-4 and IFN-7 were provided by 
Schering-Plough Research (Bloomfield, NJ). The neutralizing mAh 
19F1 recognizing both h-IL-10 and v-IL-10 has been described (J. 
Abrams et al, manuscript in preparation).
Isolation and Culture o f Human Monocytes. Human peripheral 
blood monocytes were isolated from 500-ml blood samples from 
normal donors as described previously (18,19), The monocyte prep­
aration was over >95% pure, as judged by nonspecific esterase 
staining, and contained >98% viable cells. Monocytes were cul­
tured in Yssel’s medium (14) containing HSA supplemented with 
1% pooled heat-inactivated human AB+ serum. This culture 
medium was endotoxin free as determined by the Limulus amebo- 
cyte lysate assay (< 0.2 ng/ml endotoxin). The monocytes were 
cultured at a concentration of 4 x 106 cells/ml in teflon bags 
(Jansen MNL, St. Niklaas, Belgium) and, where indicated, IFN-7 
(100 U/ml), IL4 (100 U/ml), or TT (0.5 ¿ig/ml) was added.
Proliferation Assays. Cloned T cells were used 9-12 d after stim­
ulation with feeder cells. T cells (2 x 104 cells/well were in­
cubated with irradiated (5,000 rad) autologous EBV-LCL (2 x 104 
cells/well) or HLA-DR-matched human monocytes (lOVwell) in 
the presence of antigen or antigenic peptides in 200 fi1 in round- 
bottomed (Linbro; Flow Laboratories, McLean, VA) or flat- 
bottomed plates (Falcon; Becton Dickinson & Co., Lincoln Park, 
NJ), respectively. TT was added at a concentration of 0.5 ¿¿g/ml, 
M leprae antigen (CD 104) at 1 fxg/ml, peptide amino acids 3-13 
or peptide amino acids 418-427 of 65-kD a M. leprae hsp at 0.5 
jtig/ml, D e rp  I and the D erp  1-derived peptide 89-117 at concen­
trations ranging from 10 to 0.01 ¡xg/ml. Cells were incubated for 
72 h at 37°C and 5% C 0 2, pulsed with [3H]TdR for 4 h, and 
harvested as described previously (14). The results are expressed 
as cpm of [3H]TdR incorporation and represent the mean of tripli­
cate cultures.
Immunofluorescence Analysis, Cells (105) were incubated in V-bot- 
tomed microtiter plates (Flow Laboratories) with 10 ¡jl 1 of purified
mAh (1 mg/ml) for 30 min at 4°C. After two washes with PBS 
containing 0.02 mM sodium azide and 1% BSA (Sigma Chemical 
Co., St. Louis, MO), the cells were incubated with 1:40 dilution 
of FITC-labeled F(ab')2 fragments of goat anti-mouse antibody 
(Tago, Inc., Burlingame, CA) for 30 min at 4°C. After three addi­
tional washes, the labeled cell samples were analyzed by flow 
microfluo rime try (FMF) on a FACScan® (Becton Dickinson & Co.,
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Sunnyvale, CA). The anti-MHC class II mAbs PdV5.2 (HLA-DR/ 
DP/DQ) (20), Q5/13 HLA-DR/DP (21), SPV-L3 (HLA-DQ) (14), 
and anti-CD3 (SPV-T3b) (14) were described previously).
Ca2+ Flux Measurements. T Cells at 107/ml were loaded with 
Indo-1 by incubation with its acetoxymethyl ester (Molecular Probes, 
Junction City, OR) at a concentration of 1 ¿iM for 45 min at 37°C. 
Cells were washed once and resuspended in fresh medium at 106 
cells/ml and stored at room temperature in the dark until tested. 
Calcium levels were measured by FMF with a FAC Star® plus (Becton 
Dickinson & Co.) equipped with a Coherent Innova 90 argon ion 
laser emitting 200 mW at 351/364 nm. Violet fluorescence emis­
sion (Ca2+ bound Indo-1) was detected through a 20-nm band 
pass 405-nm filter (Omega Optical, Brattleboro, VT). Blue fluores­
cence emission (free Indo-1) was measured through a 22-nm 
bandpass 485-nm filter (Omega Optical) after separation with 50:50 
beam splitter. Cells were analyzed at 37°C at typical rates of 900 cells.
Results
h-ILlO and v-ILlO Inhibit Antigen-specific Proliferation o f T  
Cells, To determine the effect of IL-10 on antigen-specific 
proliferation of human T cells, purified T cells obtained from 
donors immunized with TT were stimulated with TT  and 
autologous purified monocytes. In Fig, 1, it is shown that 
both IL-10 and v-IL-10 inhibited TT-specific proliferative re­
sponses of the T cells in a dose-dependent fashion. Significant 
inhibitory effects were already observed at IL-10 concentra­
tions of 10 U/ml, whereas maximal inhibition was obtained 
at 100 U/ml. These results indicate that specific proliferative 
responses of human T cells to soluble antigen are reduced 
by IL-10 and v-IL-10 when monocytes are used as APC. Fur­
thermore, it is shown in Table 1 that preincubation of the
monocytes for 24 h with IL-10 (100 U/ml) or v-IL-10 (100
U/ml), followed by incubation of these cells in the presence 
of purified T cells and TT (in the absence of IL-10), resulted 
in 50% reduction in the proliferative responses, as compared 
to the TT-specific proliferative responses of these T cells when 
cocultured with monocytes preincubated in medium alone.
Addition of IL-10 or v-IL-10 to the cultures of T cells, TT,
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Figure 1. The effects of IL-10 and v-IL-10 on the proliferative responses 
of peripheral blood T cells to TT  presented by autologous monocytes. 
Lymphocytes (5 x 104/well) and monocytes (2 x 104/well) were isolated 
by centrifugal élutriation and cultured in the presence of increasing con­
centrations of IL-10 and v-IL-10 for 72 h.
Table 1, Tetanus Toxoid-specific Proliferative Responses o f  
Peripheral Blood T  Cells upon Culture with Autologous 
Monocytes, Preincubated with IL -10  and v-IL-10
[3H]TdR incorporation
Culture condition + IL-10 + v-IL-10
cpm x  10'-3
T cells 3.4 1.4 1.3
T cells + monocytes 29.1 13.5 12.9
T cells + monocytes
(preincubated in medium) 49.5 14.2 13.9
T cells + monocytes
(preincubated with IL-10) 23.4 6.1 6.8
T cells + monocytes
(preincubated with v-IL-10) 22.8 5.6 7.1
Peripheral blood T  cells and monocytes were isolated by centrifugal élutri­
ation and cultured in the absence or presence of IL-10 (100 U /m l) and 
v-IL-10 (100 U /m l) .  Monocytes (2 x 104/well) were added directly to 
the T  cells (5 x lOVwell), or after preincubation for 24 h in medium, 
IL-10 (100 U /m l) ,  or v-IL-10 (100 U /m l). T T  was added at 0,5 
/ig /m l) .T he SD was <10%  in all tests.
and monocytes preincubated with IL-10 or v-IL-10 abolished 
the TT-specific proliferative responses of purified T cells al­
most completely. These results indicate that IL-10 primarily 
acts on the antigen-presenting capacity of monocytes.
ILrlO and v-IL-10 Reduce Proliferative Responses o f  Antigen- 
specific T  Cell Clones. IL-10 and v-IL-10 also inhibited in a 
dose-dependent way the proliferative responses of the TT- 
specific T cell clone 827, the Der p I-specific T cell clone 
NP14, and the T cell clone HY06, which is specific for the 
antigenic peptide 3-13 of the 65-kD M . leprae hsp, when 
monocytes were used as APC. As shown in Fig. 2, 10 U/ml 
of IL-10 or v-IL-10 was sufficient to reduce antigen-specific 
responses by 50-70%, and maximal inhibition was observed 
at 100 U/ml. However, IL-10 and v-IL-10 did not affect antigen- 
specific proliferative responses of these and several other 
antigen-specific C D 4+ T cell clones when autologous EBV- 
LCL were used as APC. The anti-IL-10 mAb 19F1 completely 
neutralized the reduced responsiveness observed in the pres­
ence of IL-10, demonstrating the specificity of the inhibition 
(Table 2). IL-10 and v-IL-10 also inhibited the proliferative 
responses towards antigenic peptides that do not require an­
tigen processing as shown (Fig. 1, Table 2). The prolifera­
tion of the Der p I-specific T cell clones NP12, NP14, and 
NP44 in response to both the whole Der p I and the Der 
p  I-derived peptide 89-117 was strongly reduced by IL-10 and 
v-IL-10. Similar results were obtained with T cell clone Rpl511, 
which is specific for the 65-kD hsp of M. leprae. Proliferation 
of this clone in response to both the whole M, leprae antigen, 
or the 65-kD hsp derived peptide 3-13 is blocked for 90% 
by IL-10 (100 U/ml) and v-IL-10 (100 U/ml). The prolifera-
917 de Waal Malefyt et al
Bo
oo
Sa.ü
o
o
o
Eaü
0
2D-
10 -
40 -
30-
1 0 -
0
1
1
1
1 0 100
1 0 100
1 0 100
5 0 0 IL-10 (U/ml)
5 0 0 IL-10 (U/ml)
500 1L-10 (U/ml)
Figure 2. The effects of IL 10 and v-IL-10 on the proliferative responses 
of CD4+ T cell clones to antigens presented by HLA-DR-mittched mono­
cytes. T cell clones (2 x lOVwell) and HLA-DR-matched monocytes 
(lOVwell) were cultured for 72 h in the presence of increasing concen­
trations of ILrlO or v-ILlO. (¿4) TT-specific T  cell clone 827 and HLA- 
DR3 + monocytes. (B) Der p  I-specifîc T  cell clone NP14 and HLA- 
D R w ll+ monocytes. (C) M. leprae-specific T  cell clone HY06 and 
HLA-DR3 + monocytes.
B
PEPTIDE 8 9 - 1 1 7  ( JJ g/mi)
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Figure 3, Proliferative responses of the Der p I—specific CD4+ T cell 
clones NP14 and NP44 to different concentrations of antigen presented 
by HLA-DR-matched monocytes in the presence of IL-10 and v-IL-10. T 
cell clones (2 x lOVwell) NP-14 (A) and NP-44 (B) and HLA-DRwll 
monocytes (lOVwell) were cultured in the presence of IL-10 (100 U/ml) 
or v-IL-10 (100 U/ml) at 10, 1, 0.1, and 0.01 pig/ml of the D erp  I-derived 
peptide 89-117 for 12 h.
tive responses of the CD4+ T cell clones HY06, CAApl515, 
and R2F10, which are specific for the 65-kD hsp-derived pep­
tides 3-13 or 418-427 and were established from different 
donors, were also strongly inhibited by IL-10 and v-IL-10. 
Again, IL-10 and v-IL-10 had no affect on the antigen-specific 
proliferative responses when the peptides were presented by
autologous EBV-LCL.
The Inhibition o f  T  Cell Proliferation by IL-10 and v-IL-10 Is 
Dependent on A n tigen  Concentration, In Fig. 3, it is shown 
that the degree of reduction of the proliferative responses of
the D er p  I-specific T cell clones NP14 and NP44 by IL-10 
and v-IL-10 depended on the antigen concentration. NP14 
and NP44 activated by the D er p  I-derived peptide 89-117 
at concentrations varying from 0.01 to 10 ¿¿g/ml, and mono­
cytes as APC showed the same degree of proliferation (Fig: 
3). Although IL-10 and v-IL-10 significantly reduced the
proliferative responses at peptide concentrations of 10 fig /ml, 
the reduction of the proliferative responses increased further 
at lower peptide concentrations. More than 90% reduction 
of the proliferative responses was observed when the D e r  p  
I-derived peptide was used at 0.01 /¿g/ml, a concentration 
that still resulted in maximal proliferative T cell responses.
These results indicate that the reduced proliferation observed 
in the presence of IL-10 is particularly pronounced when the 
antigen concentration becomes more limited.
I h l O  and v -IL lO  Strongly Downregulate Class I I M H C  M e m ­
brane Expression on Monocytes but N o t  on E B V L C L .  The results 
obtained thus far suggest that IL-10 and v-IL-10 reduce the 
effectiveness of monocytes as APC. Antigen-presenting ca­
pacity of APC has been shown to depend, among other factors, 
on the density of class II MHC molecules accommodating 
the relevant antigenic peptides (22). Therefore, the effects of 
IL-10 and v-IL-10 on constitutive HLA-DR and HLA-DQ 
expression on monocytes were investigated. HLA-DR expres­
sion on human monocytes increases during culture of these 
cells, even after incubation in teflon culture bags, which pre­
vents adhesion of the cells (Fig. 4) (23). In Fig. 4, it is fur- 
thermore shown that IL-10 strongly downregulated this in­
creased HLA-DR expression on human monocytes. IL-10 (100 
U/ml) reduced the constitutive HLA-DR expression by 90% 
after 40 h of culture. These results were confirmed by using 
several anti-class II MHC mAbs, specific for HLA-DR/DP 
or HLA-DR alone (not shown). Dose-response studies indi­
cated that inhibitory effects on HLA-DR expression were al­
ready observed at IL10 concentrations of 1 U/ml. The con-
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Table 2. Proliferative Responses of CD4+ Human T Cell Clones to Antigen Presented by HLA-DR-tnatched Monocytes or Autologous 
EBV-LCL in the Presence of IL-10 or v-IL-10
[3H]TdR Incorporation
Monocytes
EBV-LCL
Antigen
stimulation
IL-10 + 
cdL-10T cell clone — v-IL-10 IL-10 — v-IL-10 IL-10
827 TT 20.1 4.4 6.1
cpm x 10~3 
18 8.3 8.4 8.7
NP12 r -Der p I 60.1 15.2 18.5 57.5 30.5 29.4 29.5
89-117 60.1 16.8 18.5 57.5 65 59 60
NP14 r -Der p I 20.5 4.5 4.0 22.1 15.5 16.3 13
89-117 35.7 2.9 3.5 33.5 12.5 12.9 14.1
NP44 r 'Der p I 25.9 3.7 3.2 22.9 14.5 12.3 12.5
89-117 35.1 5.1 5.0 36.2 20.5 21.9 18.7
RP1511 M, leprae 79.8 11.4 12.8 ND ND ND ND
2-12 82.9 9.4 8.9 ND 54.2 52.8 54.3
HY-06 2-12 22 1.0 1.2 20 8.7 8.1 9.1
CAAP1515 2-12 9 .7 .5 ND 7 6.2 5
R2F10 2-12 46 5.8 6 ND 150 146 160
T cell clones (2 x lOVwell) and monocytes (104/well) or autologous EBV-LCL (2 x 104) were cultured in the presence of IL-10 (100 U/m l) or 
v-IL-10 (100 U/ml) for 72 h. Neutralizing anti-IL-10 mAb 19F1 was added at a concentration of 10 ¿tg/ml. v-Der p I and the Der p I-derived 
peptide 89-117 were added at concentrations of 1 /ig/ml. M, leprae and M. leprae 65-kD hsp-derived peptide 3-13 were added at 1 and 0.5 ptg/ml, 
respectively. The SD was <10% in all tests.
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Figure 4. Effects of IL-10 on HLA-DR/DP and HLA-DQ expression 
on monocytes. Monocytes (4 x 106/well) were cultured in the absence 
or presence of 100 U/ml IL-10 in medium (A and B), IL-4 (100 U/ml) 
(C), or IFN-7 (100 U/mî), (D) for 40 h and analyzed for expression of
(A) HLA-DR/DP (Q5/13), (B) HLA-DQ (SPV-L3), (C) HLA-DR/DP, 
and (D) HLA-DR/DP.
stitutive expression of HLA-DQ, which is much lower than 
that of HLA-DR, was also strongly downregulated by IL-10. 
Identical results on downregulation of class IIM H C  expres­
sion were obtained with v-IL-10 (not shown). Interestingly, 
IL-10 and v-IL-10 also strongly blocked the enhanced HLA- 
D R  and HLA-DQ expression induced by IL-4 (100 U/ml) 
or IFN-y  (1^0 U/ml). The dose-response curves shown in 
Fig. 5 for HLA-DR indicate that IL-10 seems to be more effec­
tive in counteracting the class II MHC enhancing effect of
IFN-y than that of IL-4. In contrast, IL-10 and v-IL-10 failed 
to affect constitutive HLA-DR and HLA-DQ expression on 
various EBV-LCL, as shown for NPR in Fig. 6 .
IL10 Affects the Capacity of Monocytes to Present Antigens 
as Reflected by Reduced C a2+ Fluxes in the T  Cell Clones. If 
the reduction in class II MHC expression on monocytes by 
IL-10 accounts for the strongly reduced antigen-specific 
proliferative responses, this would imply that we are dealing 
with a reduced capacity to induce T cell activation. If this 
conclusion is correct, reduced stimulatory capacity of mono­
cytes as APC should be reflected in reduced induction of 
Ca2+ mobilization in the responding T cell clones. In Fig.
7, it is shown that Ca2+ fluxes induced in T cell clone 827 
were suppressed by ~70% when monocytes preincubated 
with TT and IL-10 were used to activate the T cell clone. 
Ca2+ fluxes induced by an anti-CD3 mAb were used as con-
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Figure 5. Effects of IL-10 on HLA- 
DR/DP and HLA-DQ expression on 
human monocytes cultured in the pres­
ence of IL-4 or IFN-y. Monocytes (4
x 106/well) were cultured in the pres­
ence of (^ 4) IL-4 (100 U/ml), or (B) 
IFN-y (100 U/ml), and 0, 1, 10, and 
100 U/ml IL-10, and analyzed for ex­
pression of HLA-DR/DP (Q5/13).
trols. In the presence of IL-10, but in the absence of mono­
cytes, no changes were observed in the Ca2+ fluxes of the 
T cell clone in response to anti-CD 3 mAb s. However, when 
monocytes, preincubated with TT in the presence of IL-10, 
were added to the T cell clones, strong reductions in both 
the plateau levels of the Ca2+ fluxes and the percentage of 
positive cells were observed, as compared to the Ca2* fluxes 
induced by monocytes that were preincubated with TT alone. 
It has to be noted that Ca2+ fluxes could be measured at the 
earliest 3-4 min after addition of the monocytes to the T 
cells, because a 2-min centrifugation step was required in order 
to establish optimal T cell/APC contacts.
Reduced Antigen-specific T Cell Proliferation Induced by IL-10 
and v-ILlO, Cannot be Neutralized by Exogenous IL2 or IL-4, 
The results thus far suggest that the reduced proliferative re­
sponses of the T cell clones observed in the presence of IL-10
and v-IL-10 are related to a reduced capacity of monocytes 
to present antigen, which leads to an incomplete activation 
of the T cell clone. Since IL-10 has cytokine synthesis inhibi­
tory (CSI) activity (de Waal Malefyt et al., manuscript in 
preparation), the effects of IL-2 and IL-4 on the inhibition 
of antigen-specific proliferative responses were examined. In 
Kg. 8, it is shown that IL-10 and v-IL-10 inhibited the antigen- 
specific response of T cell clone 827 to TT with monocytes 
as APC by 85-90%. The addition of increasing amounts of 
IL-2 to these cultures resulted in enhanced proliferative re­
sponses, both in the presence or absence of IL-10, until a pla­
teau was reached at concentrations of 1,000 U/ml. Addition 
of IL-2 at concentrations of up to 100 U/ml, which is sufficient 
to saturate high affinity IL2Rs, had no effect on the inhibi­
tion of antigen-specific T cell proliferation by IL-10. Even 
at IL-2 concentrations of >1,000 U/ml, still 30-40% inhibi-
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HLA-DQ Figure 6. The effects of IL-10 on 
HLA-DR/DP and HLA-DQ expres­
sion on EBV-LCL. EBV-LCL NPR (5
x 105/well) were cultured in the ab­
sence (A and C), or in the presence (B 
and D) of IL-10 (100 U/ml) and ana­
lyzed for expression of (A and B) HLA-
D R  (Q5/13) and HLA-DQ (SPV-L3).
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the IL-10-mediated inhibition of antigen-specific proliferation 
of this T cell clone.
Expression of IL-2Ra: or IL-2R/3 chains of T cell clones 
that were cultured for up to 72 h in the presence of IL-10 
or v-IL-10 was not modulated (not shown). Collectively, these 
data indicate that reduced antigen-presenting capacity of mono­
cytes caused by IL-10-mediated downregulation of class II 
MHC expression leads to incomplete activation of the T cell 
clones that can only be partially rescued by very high con­
centrations of exogenous IL-2, but not by IL-4.
Discussion
IL-10 and its viral counterpart, v-IL-10, can completely pre­
vent the specific proliferative responses of CD4+ T cells and 
CD4+ T cell clones towards various protein antigens and 
antigenic peptides. Reduced antigen-specific proliferative re­
sponses were observed only when monocytes, and not when 
autologous or allogeneic EBV-LCL carrying the appropriate 
restriction elements, were used as APC. These results are in 
line with observations made in murine systems where Fioren- 
tino et al. (2) showed that IL-10 inhibited IFN-7  production 
tion was observed. These results indicated that inhibition of by mouse T helper cell clones when monocytes, but not when 
IL-2 production, due to the CSI activity of IL-10, could only B cells, were used as APC. Interestingly, the reduced respon-
Figure 7. Induction of Ca2+fluxes in T cell clone 827 by anti-CD3 
mAb and to antigen presented by monocytes, preincubated with IL-10. 
Intracellular Ca2+ concentrations were measured in T cell clone 827 in 
response to anti-CD3 mAb, anti-CD3 mAb + IL-10 (100 U/ml),, mono­
cytes preincubated with TT (0.5 ¡xg/ml), and monocytes preincubated with 
TT and IL-10 (100 U/ml). Anti-CD3 mAbs were added at 0 min. T cells
and monocytes were centrifuged for 2 min to establish cell-cell contacts, 
gently resuspended, and analyzed on the FACS®.
partially account for the inhibition of antigen-specific prolifer­
ation of T cell clone 827. Furthermore, it is shown in Fig. 
8 that monocytes and high concentrations of IL-2 were able 
to induce proliferation of the T cell clones in the absence
siveness was partially restored by exogenous IL-2, but only 
at very high concentrations of >1,000 U/ml, suggesting that 
the reduced proliferation observed in the presence of IL-10 
and v-IL-10 under the present culture conditions was not a
of antigen. These responses were also inhibited by IL-10. How- mere consequence of inhibition of endogenous IL-2 produc-
ever, the proliferative responses of T cell clone 827 to IL-2 tion, due to CSI activity of IL-10 or v-IL-10. This observa-
in the absence of monocytes were, as expected, not affected tion is compatible with murine studies that have indicated
by IL-10. Identical results were obtained with v-IL-10 (not that m-IL-10 (CSIF) had only weak inhibitory effects on IL-2
shown). Addition of increasing amounts of IL-4 to the T cell production by Thl cells after activation by antigen presented
by macrophages (1). In addition, these studies showed that 
m-IL-10 still suppressed the production of IFN-7  by Thl clones
clone 827 activated by TT and monocytes as APC completely 
failed to affect the antigen-specific proliferative responses, ei­
ther in the absence or in the presence of IL-10 and v-IL-10 when these experiments were performed in the presence of 
(not shown). This indicated that IL-4 was not involved in saturating quantities of IL-2 (1). IL-10 and v-IL-10 also re-
827
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Figure 8. Effects of IL-2 on the re­
duced antigen-specific proliferative re­
sponses of CD4+ T cell clone 827 in­
duced by IL-10. T cell clone 827 (2 x 
lOVwell) was cultured with increasing 
amounts of IL-2 under the following 
conditions: (2) with monocytes 
(IQ4/well) and TT (0.5 /xg/ml); (2) 
with monocytes, TT, and IL-10 (100 
U/ml); (3) with monocytes in the ab­
sence of TT; (4) with monocytes and 
IL-10 in the absence of TT; (5) with TT 
in the absence of monocytes; and (5) 
with TT and IL-10 in the absence of
1000 10000 IL-2 (U/ml) monocytes,
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duced the proliferative responses to antigenic peptides, which 
do not require processing (24, 25), indicating that the in­
hibitory effects of IL-10 and v-ILlO are not related to inhibi­
tion of antigen processing by the monocytes. Comparable 
data were obtained in murine studies that demonstrated that 
m-IL-10 also reduced cytokine production after activation by 
superantigens that do not require processing (2). Murine 
studies furthermore indicated that m-IL-10 suppressed lym- 
phokine production by Thl cells (1). Human CD4+ T cell 
clones cannot generally be divided in Thl or Th2 subsets 
(11,12). However, the Derp I-specific T cell clones have been 
shown to produce very high levels of IL-4 and IL-5 and low 
to normal levels of IL-2 and IPN-7 . Because of these aberrant 
IL-4/IFN-y production ratios, these clones were designated 
as “Th2-like” cells (Yssel et al, manuscript submitted for pub­
lication). In contrast, theM leprae-specific T cell clones pro­
duced unusually high levels of IFN-y, and undetectable or 
very low levels of IL-4 and IL-5, and were therefore consid­
ered to represent “Thl-like” cells (13). Although these clones 
do not fully represent murine Thl or Th2 cells, it is of in­
terest to note that IL-10 and v-IL-10 inhibited the prolifera­
tion of both the Der p I- and the M. leprae-specific clones 
equally well.
IL-10 and v-IL-10 strongly downregulated constitutive class 
IIMHC expression on human monocytes. IL-10 and v-IL-10 
not only downregulated constitutive class II MHC expres­
sion, but also blocked the class II MHC enhancing effects 
of IFN-y and IL-4 in a dose-dependent fashion. IL-10 and 
v-IL-10 failed to modulate class I MHC expression on mono­
cytes and did not affect the levels of CDlla, CDllb, CDllc, 
CD18, CD54 (ICAM-1), CD58 (LFA-3), CD14, CD44, 
VLA-4, VLA-5, VLA-6, CD23, and CD25 (results not
shown). These results indicate that the reduction in the 
antigen-presenting capacity of monocytes is not due to inhi­
bition of intercellular adhesion molecules that either directly 
(26, 27), or by mediating T cell APC contacts, play an im­
portant role in T cell activation and proliferation. The obser­
vation that the APC function of EBV-LCL was not affected 
by IL-10 and v-IL-10 tested over a wide concentration range 
and after prolonged incubation times (up to 4 d), together 
with the fact that IL-10 and v-IL-10 failed to downregulate 
class II MHC expression on these cells, suggested that the 
reduction in antigen-specific proliferative responses of CD4* 
T cells and T cell clones could be associated with the strong 
reduction in surface class II MHC expression on the mono­
cytes. Harding & Unanue (28) recently have shown that ^300 
class II MHC-specific antigenic peptides complexes on APC 
representing only 0.1-0.2% of the restricting class II MHC 
molecules were sufficient to induce T cell proliferation. Their 
studies furthermore indicated that most class II MHC mole­
cules were not occupied by the antigenic peptide, but prob­
ably by self or other antigenic peptides (28). Such a very low 
percentage of class II MHC molecules accommodating the 
specific peptides may account for the observation that the 
proliferative responses were reduced by >90%, whereas there 
was still considerable surface class II MHC expression on the 
monocytes. In addition, it was shown recently that antigenic 
peptides need to associate with newly synthesized HLA-DR
molecules before cell surface expression (29, 30). Recycling 
of class II MHC molecules (31), or association of peptides 
with ‘‘empty” class II MHC molecules expressed on the cell 
surface, do not significantly contribute to the expression of
immunogenic class II MHC peptide complexes (29-31). This 
suggests that class II MHC synthesis and cell surface expres­
sion of new MHC class II/peptide complexes is particularly 
important for antigen presentation. It is possible that this 
process is downregulated by IL10. This notion is further sup­
ported by the observation that reduction of the proliferative 
responses was more pronounced when the antigen concen­
tration became limiting. From these observations, it can be 
concluded that IL-10 and v-IL-10 in these culture systems do 
not act as suppressor factors, but that the reduction in antigen- 
specific T cell proliferation in the presence of monocytes as 
APC merely reflects a strong reduction in the antigen- 
presenting capacity of these cells. This contention was com­
patible with the observations that the [Ca2+]i fluxes were 
strongly reduced when the TT-specific T cell clones were 
stimulated by monocytes preincubated with TT in the pres­
ence of IL-10 or v-IL-10 and that neither IL-2-induced prolifer­
ation nor the expression of IL-Ra and IL2R/3 chains on the 
T cell clones was affected by IL-10 and v-IL-10.
More recently, we have demonstrated that IL-10 and v-IL-
10 strongly inhibit the production of IL-la, IL1/3, IL-6, IL-8, 
TNF-a, and granulocyte/macrophage (GM)-CSF (31a). IL-la, 
IL-ljS, and also IL-6, TNF-a and GM-CSF have been shown 
to have costimulatory effects on antigen-specific T cell prolifer­
ation (32-35). However, it was excluded that the strong reduc­
tion in antigen-specific proliferative responses was due to in­
hibition of the production of these monokines, because reduced 
responsiveness could not be neutralized by addition of 
saturating concentrations of these monokines. In addition, 
it was demonstrated that under the present culture condi­
tions, antibodies against these monokines did not decrease 
the antigen-specific proliferative T cell responses (not shown). 
It was also ruled out that IL-10 induced the production of 
TGF-/3 (36), or other unknown soluble suppressor factors 
by monocytes. Supernatants of cultures in which strong reduc­
tion in T cell proliferation was obtained in the presence of 
monocytes, TT, and IL-10, failed to affect the specific prolifer­
ative responses of T cell clones induced by TT presented by 
autologous EBV-LCL (not shown). Furthermore, freshly iso­
lated monocytes added in relatively high concentrations to 
cultures of TT-specific T cell clones, TT, and autologous EBV- 
LCL as APC failed to reduce the proliferative responses of 
these clones in the presence of IL-10, indicating that IL-10 
did not induce these *'‘bystander” monocytes to release factors 
suppressing antigen-specific T cell proliferation. In addition, 
supernatants of monocytes cultured in the presence or ab­
sence of IL-10 and tested in the presence of the neutralizing 
anti-IL-10 mAb failed to enhance the TT-specific prolifera­
tive responses of T cell clones sub optimally activated by TT 
and autologous EBV-LCL. This argues against the idea that 
IL-10 could suppress the production of a putative soluble mono­
cyte factor, which has costimulatory activity on antigen-specific 
T cell proliferation.
Collectively, our data indicate that both-10 and v-IL-10
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through downregulation of class II M HC molecules on mono­
cytes strongly reduce the antigen-presenting capacity of these 
cells, thereby reducing, or preventing, optimal antigen-specific 
proliferative T cell responses.
Recently, we have shown that monocytes stimulated by 
LPS produce IL-10. However, IL-10 is produced late (24-36 
h) after activation (31a), whereas ILlo:, IL-1/3, IL-6, and TNF-a:
are generally maximally produced after 8-12 h of activation 
(37). These kinetics of IL-10 production by monocytes, 
together with its inhibitory effects on proinflammatory 
monokine production and its downregulatory effects on class 
II M HC molecules, suggest that IL-10 in an autocrine fashion 
may play a role in damping immune responses.
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